பீட்டர் ஸ்டீன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பீட்டர் ஸ்டீன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பீட்டர் ஸ்டீன் Today - Breaking & Trending Today

FDA Releases First Long-Acting Insulin Analog to Aid Diabetics


Wednesday, August 4, 2021
Has the Food and Drug Administration (FDA) finally ushered in a new era for the U.S. biosimilar marketplace? Many in the industry are hopeful after the Agency approved its first interchangeable biosimilar, Mylan’s Semglee (insulin glargine) on July 28, 2021. Mylan’s Semglee is a long-acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. It is both biosimilar to and interchangeable with Lantus (insulin glargine) meaning it can be substituted for Lantus at the pharmacy level without the need for a prescription from a healthcare professional. This approval is important because it furthers FDA’s commitment to supporting a competitive marketplace for insulin products. The availability of interchangeable biosimilar products can provide more treatment options to patients, lowering the treatment costs and enabling greater acc ....

United States , Peter Stein , Mylan Semglee , Office Of New Drugs , Drug Administration , Biosimilars Action Plan , Federal Trade Commission , New Drugs , Drug Evaluation , ஒன்றுபட்டது மாநிலங்களில் , பீட்டர் ஸ்டீன் , அலுவலகம் ஆஃப் புதியது மருந்துகள் , கூட்டாட்சியின் வர்த்தகம் தரகு , புதியது மருந்துகள் , மருந்து மதிப்பீடு ,